Clinical Trials Browser

Phase 2 × Ependymoma × abemaciclib × Clear all

NCT03220646 2025-07-09

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

Phase 2 Active not recruiting

Astrocytoma, Brain Neoplasms, Ependymoma, Meningioma, Oligodendroglioma